- Opioid Use Disorder Treatment
- Cardiac Arrest and Resuscitation
- Pain Management and Opioid Use
- Substance Abuse Treatment and Outcomes
- Cannabis and Cannabinoid Research
- Sexuality, Behavior, and Technology
- LGBTQ Health, Identity, and Policy
- HIV, Drug Use, Sexual Risk
- Prenatal Substance Exposure Effects
- Reproductive Health and Technologies
- Long-Term Effects of COVID-19
- COVID-19 and healthcare impacts
- COVID-19 and Mental Health
Washington State University Spokane
2021-2023
Georgia Highlands College
2022-2023
Washington State University
2022-2023
British Columbia Centre on Substance Use
2020
Background Background: In response to the COVID-19 pandemic, US Substance Abuse and Mental Health Services Administration (SAMHSA) allowed for an increase in methadone take-home doses treatment of Opioid Use Disorder (OUD) March 2020.
In this article, we describe a community-based research (CBR) approach to making national online survey of gay, bisexual, and other men who have sex with (GBMSM) inclusive transgender GBMSM by working members the community at all stages process. This collaboration resulted in 209 completing our contrasted their health experiences 7439 cisgender GBMSM. We found that were less likely than report intercourse without condom (AOR 0.43; 95% CI: 0.28-0.66) had an HIV test 0.64; CI 0.49-0.85)....
Background: An exemption to existing U.S. regulation of methadone maintenance therapy after the onset COVID−19 pandemic permitted increased take-home doses beginning March 2020.Objectives: We assessed impact this on opioid use.Methods: A pre/post study 187 clients recruited from an OTP who completed a survey and consented share their urine drug testing (UDT) data. Use fentanyl, morphine, hydromorphone, codeine, heroin was via UDT. Receipt clinic records for 142 working days pre- post-COVID...
Objectives: The US Substance Abuse and Mental Health Services Administration (SAMHSA) authored an exemption to its existing regulation of methadone maintenance therapy after the onset COVID-19 pandemic. This allowed for increase in take-home doses permitted treatment opioid use disorder beginning March 2020. We assessed impact this on use.Methods: A cross-sectional pre/post study 187 clients recruited from a clinic who completed survey consented share their urine drug testing data. Use...